Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Furocyst for management of PCOS – white paper
Download this white paper to learn about a patented product derived from a single herb that has been shown to support women with PCOS.
June 9, 2020
1 Min Read
Sponsored by Chemical Resources
Polycystic ovarian syndrome (PCOS) affects an estimated 1 in 10 women, which is why National Institutes of Health (NIH) has announced it as a major public-health issue for women. PCOS is of clinical and public health importance as its prevalence is very high among women of reproductive age.
Furocyst® is a patented product derived from a single herb with a proprietary manufacturing process involving separation of active ingredients without affecting chemical properties of the active fractions. Learn more in this white paper.
You May Also Like